Company intelligence / Profile preview

CareSpeak Communications

Somerset, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

CareSpeak's patient engagement platform has demonstrated improved adherence, better patient outcomes, and healthcare cost reduction (e.g., up to 83% reduction in liver rejections for pediatric liver transplant, 15% increase in adherence in coronary heart disease, reduced payer medical cost by $140 per member per month)[2][8].

Therapeutic areas: CardiovascularImmunologyEndocrinologyOtherOncology
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Partnerships

Molina HealthcareUnitedHealthPharmaceutical companiesSpecialty pharmaciesHealth plans

Beyond the preview

Go deeper on CareSpeak Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareSpeak Communications.

Explore the full profile